Sign in
IMV Stock Price, Chart, Stats & News
IMV Inc.
Save
IMV Inc. (IMV) does not currently pay a dividend.
13.12M
Market cap
–
Current P/E
–
Forward P/E
IMV chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
IMV Inc. is a clinical-stage biotechnology company dedicated to the development of innovative immunotherapies. The company utilizes its proprietary DPX immune-educating technology platform to create a portfolio of treatments for various solid and hematological cancers. Its leading investigational drug, maveropepimut-S, is a DPX-based immunotherapy designed to target cancer cells that express survivin.
Similar securities
Based on sector and market capitalization
Report issue